Developer docs
API playgroundTry for free, no card

Search company profiles

Consilient Health

Full company profile

uuid000fcvi

Namestring
Consilient Health
Legal namestring
Consilient Health Limited
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Consilient Health Limited is a Dublin-headquartered, privately held pharmaceutical company founded in 2005 that commercializes niche and differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets (Sweden, Norway, Denmark, Finland), with partnership-driven extensions into Benelux and Spain. The company runs three regional platforms — consilienthealth.co.uk, consilienthealth.ie, and consilienthealth.nu — and pursues a licensing/royalty revenue model anchored by long-term strategic partnerships with both small biotech firms and large publicly listed manufacturers. Its offering spans the full in-country commercialization stack: regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales, performed by in-house country-led teams in each operating region. The technology underpinning the business is a pharmaceutical commercialization and distribution platform rather than a software product, with value created through product registration, market access, and direct sales execution rather than proprietary code.

Consilient Health is profitable and independent, with majority ownership held by Non-Executive Chairman Shane Reihill's family investment vehicle. Leadership is headed by CEO Luke Crosbie (appointed May 2022 after serving as Executive Vice Chairman since 2005), with COO Dr Roger Wu, CMO Dr Anne Fairey, and Finance Director John Fagan, alongside a non-executive board featuring senior industry figures including ex-Boehringer Ingelheim UK/Ireland MD John Dixon and ex-Grunenthal/ArjoHuntleigh CEO Harald Stock. In February 2023 the company divested its OC Distributors subsidiary (Ireland-based, women's healthcare) to Gedeon Richter plc for GBP 32.5 million, signaling portfolio refocusing on its differentiated-prescription core; the same period saw a deliberate scaling of the Business Development function with multiple senior hires in 2023 and 2024 to expand the in-licensing pipeline. The company has no disclosed external funding, no parent company, and no public listing.

Short descriptiontext

Consilient Health is a privately held, profitable Dublin-based pharmaceutical company that in-licenses and commercializes niche, differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets through long-term partnerships with biotech and pharma manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription pharmaceutical commercialization, pharmaceutical licensing partnerships, specialty pharmaceutical distribution, market access services, European pharmaceutical marketing
Industry2 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Commercialization
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Commercialization
TypeLicensing Royalties
Description

Consilient Health generates revenue by commercializing prescription healthcare products through strategic partnerships with pharmaceutical companies. The company focuses on products that address unmet clinical needs, managing market access, marketing, sales, and distribution in the UK and European markets.

consilienthealth.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Consilient Health commercializes niche and differentiated prescription pharmaceutical products across multiple therapeutic areas in the UK and European markets through strategic partnerships with pharmaceutical developers and manufacturers. The company evaluates products and focuses on those with potential to address clear unmet clinical needs, managing market access, marketing, sales, and distribution on behalf of partners. Its operations span regulatory affairs, supply chain, distribution, medical affairs, marketing, and sales across UK, Ireland, and the Nordics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Consilient Health is a pharmaceutical company that commercializes differentiated and niche prescription healthcare products across multiple therapeutic areas. The company operates through regional platforms for Ireland (consilienthealth.ie), the United Kingdom (consilienthealth.co.uk), and the Nordic region (consilienthealth.nu), offering prescription medicines through partnerships with pharmaceutical developers and manufacturers. The company focuses on products addressing unmet clinical needs, with capabilities spanning regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales. Specific product names are available on the regional websites rather than the main corporate site.

Product and service5 records
1Prescription Pharmaceutical Commercialization (UK)
CategoryPharmaceutical Commercialization
Description

Licensing and commercialization of niche and differentiated prescription pharmaceutical products in the UK market through direct sales and marketing operations, serving pharmaceutical companies seeking market access without their own UK infrastructure.

2Prescription Pharmaceutical Commercialization (Ireland)
CategoryPharmaceutical Commercialization
Description

Licensing and commercialization of prescription pharmaceutical products across Ireland and Malta, established with a dedicated country team and offering primary and secondary care market access.

3Prescription Pharmaceutical Commercialization (Nordics)
CategoryPharmaceutical Commercialization
Description

Licensing and commercialization of prescription pharmaceutical products across Sweden, Norway, Denmark, and Finland, with a regional headquarters in Uppsala, Sweden, and partnerships extending into Benelux and Spain.

4Generic Pharmaceuticals (UK)
CategoryGeneric Pharmaceuticals
Description

UK generic pharmaceuticals business and trade management servicing large retail chains and national wholesalers, also managing international export opportunities.

5Women's Healthcare Products (OC Distributors Ltd)
CategoryWomen's Healthcare Pharmaceuticals
Description

Previously marketed and distributed women's healthcare products in Ireland via wholly-owned subsidiary OC Distributors Ltd; in February 2023 the subsidiary was sold to Gedeon Richter plc.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Gedeon Richter plc
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2023-02-09
Description

Consilient Health shareholders sold 100% control of OC Distributors Ltd, an Ireland-based company holding marketing and distribution rights for women's healthcare products, to Gedeon Richter plc. Transaction valued at GBP 32.5 million.

consilienthealth.com
2Sustainable Medicines Partnership (SMP)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-12
Description

Consilient Health joined the Sustainable Medicines Partnership as a Founding Collaborator. SMP is a not-for-profit, private-public, multi-stakeholder collaborative aimed at stopping the avoidable waste of medicines and medicines packaging. Through a four-year programme, SMP aims to build science-based, scalable, sustainable solutions to reduce medicine waste and healthcare emissions globally.

consilienthealth.com
3Pharmaceutical Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consilient Health has established long-term, mutually beneficial partnerships with pharmaceutical developers and manufacturers spanning from small innovative biotech firms to large publicly listed companies. The company seeks partnerships with companies that share high ethical standards, are performance-driven, and committed to long-term collaborations.

consilienthealth.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Consilient Health

Pharmaceutical Commercializationconsilienthealth.com

Consilient Health is a privately held, profitable Dublin-based pharmaceutical company that in-licenses and commercializes niche, differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets through long-term partnerships with biotech and pharma manufacturers.

What Consilient Health does

Consilient Health Limited is a Dublin-headquartered, privately held pharmaceutical company founded in 2005 that commercializes niche and differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets (Sweden, Norway, Denmark, Finland), with partnership-driven extensions into Benelux and Spain. The company runs three regional platforms — consilienthealth.co.uk, consilienthealth.ie, and consilienthealth.nu — and pursues a licensing/royalty revenue model anchored by long-term strategic partnerships with both small biotech firms and large publicly listed manufacturers. Its offering spans the full in-country commercialization stack: regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales, performed by in-house country-led teams in each operating region. The technology underpinning the business is a pharmaceutical commercialization and distribution platform rather than a software product, with value created through product registration, market access, and direct sales execution rather than proprietary code.

Consilient Health is profitable and independent, with majority ownership held by Non-Executive Chairman Shane Reihill's family investment vehicle. Leadership is headed by CEO Luke Crosbie (appointed May 2022 after serving as Executive Vice Chairman since 2005), with COO Dr Roger Wu, CMO Dr Anne Fairey, and Finance Director John Fagan, alongside a non-executive board featuring senior industry figures including ex-Boehringer Ingelheim UK/Ireland MD John Dixon and ex-Grunenthal/ArjoHuntleigh CEO Harald Stock. In February 2023 the company divested its OC Distributors subsidiary (Ireland-based, women's healthcare) to Gedeon Richter plc for GBP 32.5 million, signaling portfolio refocusing on its differentiated-prescription core; the same period saw a deliberate scaling of the Business Development function with multiple senior hires in 2023 and 2024 to expand the in-licensing pipeline. The company has no disclosed external funding, no parent company, and no public listing.

Consilient Health firmographics

Firmographics
Name
Consilient Health
Legal name
Consilient Health Limited
Website
https://consilienthealth.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Consilient Health is a privately held, profitable Dublin-based pharmaceutical company that in-licenses and commercializes niche, differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets through long-term partnerships with biotech and pharma manufacturers.
Ownership category
akta.pro rank

Consilient Health industry classification

Industry
Product category
Pharmaceutical Commercialization
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Prescription pharmaceutical commercialization
  • Pharmaceutical licensing partnerships
  • Specialty pharmaceutical distribution
  • Market access services
  • European pharmaceutical marketing

Where Consilient Health is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices3 records

Markets served

Consilient Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Pharmaceutical Product Commercialization: Consilient Health generates revenue by commercializing prescription healthcare products through strategic partnerships with pharmaceutical companies. The company focuses on products that address unmet clinical needs, managing market access, marketing, sales, and distribution in the UK and European markets.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Consilient Health product offering

Product offering

Core offering

Consilient Health commercializes niche and differentiated prescription pharmaceutical products across multiple therapeutic areas in the UK and European markets through strategic partnerships with pharmaceutical developers and manufacturers. The company evaluates products and focuses on those with potential to address clear unmet clinical needs, managing market access, marketing, sales, and distribution on behalf of partners. Its operations span regulatory affairs, supply chain, distribution, medical affairs, marketing, and sales across UK, Ireland, and the Nordics.

Product overview

Consilient Health is a pharmaceutical company that commercializes differentiated and niche prescription healthcare products across multiple therapeutic areas. The company operates through regional platforms for Ireland (consilienthealth.ie), the United Kingdom (consilienthealth.co.uk), and the Nordic region (consilienthealth.nu), offering prescription medicines through partnerships with pharmaceutical developers and manufacturers. The company focuses on products addressing unmet clinical needs, with capabilities spanning regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales. Specific product names are available on the regional websites rather than the main corporate site.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prescription Pharmaceutical Commercialization (UK) Licensing and commercialization of niche and differentiated prescription pharmaceutical products in the UK market through direct sales and marketing operations, serving pharmaceutical companies seeking market access without their own UK infrastructure.
  • Prescription Pharmaceutical Commercialization (Ireland) Licensing and commercialization of prescription pharmaceutical products across Ireland and Malta, established with a dedicated country team and offering primary and secondary care market access.
  • Prescription Pharmaceutical Commercialization (Nordics) Licensing and commercialization of prescription pharmaceutical products across Sweden, Norway, Denmark, and Finland, with a regional headquarters in Uppsala, Sweden, and partnerships extending into Benelux and Spain.
  • Generic Pharmaceuticals (UK) UK generic pharmaceuticals business and trade management servicing large retail chains and national wholesalers, also managing international export opportunities.
  • Women's Healthcare Products (OC Distributors Ltd) Previously marketed and distributed women's healthcare products in Ireland via wholly-owned subsidiary OC Distributors Ltd; in February 2023 the subsidiary was sold to Gedeon Richter plc.

Companies that use Consilient Health

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Consilient Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Consilient Health partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered major and core.

  • Gedeon Richter plcmajorStrategic or Co-development Partner · 9 February 2023Consilient Health shareholders sold 100% control of OC Distributors Ltd, an Ireland-based company holding marketing and distribution rights for women's healthcare products, to Gedeon Richter plc. Transaction valued at GBP 32.5 million.
  • Sustainable Medicines Partnership (SMP)coreStrategic or Co-development Partner · 12 January 2023Consilient Health joined the Sustainable Medicines Partnership as a Founding Collaborator. SMP is a not-for-profit, private-public, multi-stakeholder collaborative aimed at stopping the avoidable waste of medicines and medicines packaging. Through a four-year programme, SMP aims to build science-based, scalable, sustainable solutions to reduce medicine waste and healthcare emissions globally.
  • Pharmaceutical PartnerscoreStrategic or Co-development PartnerConsilient Health has established long-term, mutually beneficial partnerships with pharmaceutical developers and manufacturers spanning from small innovative biotech firms to large publicly listed companies. The company seeks partnerships with companies that share high ethical standards, are performance-driven, and committed to long-term collaborations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Consilient Health competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Consilient Health social profiles

Digital presence

Consilient Health compliance and trust

Trust signal

Compliance5 records

Consilient Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Consilient Health leadership team

Management profile

Number of profiles

Profiles17 records

Consilient Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Consilient Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Consilient Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Consilient Health

What does Consilient Health do?

Consilient Health commercializes niche and differentiated prescription pharmaceutical products across multiple therapeutic areas in the UK and European markets through strategic partnerships with pharmaceutical developers and manufacturers. The company evaluates products and focuses on those with potential to address clear unmet clinical needs, managing market access, marketing, sales, and distribution on behalf of partners. Its operations span regulatory affairs, supply chain, distribution, medical affairs, marketing, and sales across UK, Ireland, and the Nordics.

Is Consilient Health a public or private company?

Consilient Health is a private company. It is classified as family owned and is currently operating.

When was Consilient Health founded?

Consilient Health was founded in 2005. It employs 51 to 100 people.

Where is Consilient Health based?

Consilient Health is headquartered in Dublin, Ireland, in the Europe region.

How does Consilient Health make money?

One revenue line is on record: pharmaceutical Product Commercialization.

Does Consilient Health have an API?

No public API is recorded for Consilient Health.

What industry is Consilient Health in?

Consilient Health's product category is Pharmaceutical Commercialization. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals